Health Condition 1: M750- Adhesive capsulitis of shoulder
Conditions
Interventions
Intervention1: Group-I (IA-Dextrose prolotherapy injection group): Ultra sound guided Intra-Articular Injection (Glenohumeral joint) of 4ml 12.5% Dextrose solution (2ml of 2% Lignocaine and 2ml of 25%
Sponsors
AIIMS Bhubaneswar
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged between 25-60 years of both genders. 2. Patients with AC with duration of symptoms more than 3 months. 3. Patients who have a normative radiograph finding of the affected shoulder. 4. Moderate to severe pain (VAS > 50). 5. Limitation of both active and passive movements of the shoulder joint of 25% or more in 2 or more directions (abduction,flexion,external rotation,internal rotation).
Exclusion criteria
Exclusion criteria: 1. Patients with secondary Adhesive Capsulitis (secondary to inflammatory joint disease, structural/functional limitations in the shoulder joint from any other pre-existing musculoskeletal pathology or neurologic disorder). 2. Patients who have previously undergone any Intra Articular injection/invasive procedure/surgery in the shoulder joints. 3. uncontrolled DM. 4. Poor cognitive status, who are unable to follow exercise program.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analog Scale (VAS) for Pain intensityTimepoint: At baseline (V0), 3 weeks (V1) after injection, 6 weeks (V2) after injection and 12 weeks (V3) after injection | — |
Secondary
| Measure | Time frame |
|---|---|
| Shoulder Pain and Disability Index (SPADI) questionnaire, Active and Passive range of motion of the Shoulder using universal goniometer, WHO-QOL BREF questionnaire for assessment of change in Quality of life.Timepoint: at baseline, at 3 weeks, at 6 weeks and at 12 weeks after the intervention. | — |
Countries
India
Contacts
Public ContactDr Kamal Verma
AIIMS, Bhubaneswar
Outcome results
None listed